期刊文献+

规律性尿激酶封管对血液透析患者长期留置深静脉导管功能的影响 被引量:5

Effect of regular urokinase sealing tube on the function of long term indwelling deep venous catheter in hemodialysis patients
下载PDF
导出
摘要 目的:探讨规律性尿激酶封管对长期留置深静脉导管功能改善的作用以及使用寿命的影响。方法:选取2013年5月~2014年5月我院血液净化中心进行血液透析患者292例,根据封管方式不同分为对照组和观察组,对照组采用常规肝素溶液封管;观察组每周第1次治疗时使用25000 U/ml尿激酶加25 mg/ml肝素溶液封管。两组患者均连续观察12个月。结果:两组不同封管方式对患者凝血功能无明显影响,但观察组在12个月内长期中心静脉导管的功能不良发生率明显低于对照组,其使用时间明显比对照组长,差异有统计学意义(P〈0.05)。结论:规律性尿激酶封管对长期留置深静脉导管功能有明显的改善作用,并能延长其使用寿命。 Objective: To discuss and investigate the improvement and service life change of long term indwelling deep venous catheter by the application of regular urokinase sealing tube.Methods: Selected 292 hemodialysis patients who received blood purification in the blood purification center of our hospital were selected from May 2013 to May 2014 and they were divided into two groups according to different tube sealing methods,the control group and the observed group.Conventional heparin tube sealing tube was applied in the control group,while 25000 U/ml urokinase and 25 mg/ml heparin sealing was applied in the observed group for the first time of treatment every week.The two groups were observed for a consecutive 12 months.Results: There was no significant difference in the blood coagulation function between patients of the two groups,however,the dysfunction rate for the central venous catheter in the long term within 12 months of the observed group was significantly lower than that of the control group,and the service life of the central venous catheter was significantly longer than that of the control group( P〈0.05).Conclusion: The regular urokinase sealing tube can obviously improve the function of long term indwelling deep venous catheter and can extend its service life.
机构地区 解放军第
出处 《护理实践与研究》 2016年第6期35-36,共2页 Nursing Practice and Research
关键词 中心静脉导管 尿激酶封管 血液透析 Central venous catheters Urokinase sealed tube Hemodialysis
  • 相关文献

参考文献5

二级参考文献27

  • 1夏娟,马玉英,居建忻.肝素尿激酶混合液在血液透析双腔导管封管中的应用[J].解放军护理杂志,2005,22(6):18-19. 被引量:16
  • 2孟秀云,姜立萍,杨敏,刘宁.尿激酶不同给药方法对隧道导管纤维蛋白鞘的影响[J].中华护理杂志,2005,40(10):782-783. 被引量:23
  • 3刘春来,刘锁民,刘屹立,王平.尿激酶治疗血液透析患者动静脉内瘘血栓形成的临床体会[J].疑难病杂志,2006,5(3):198-199. 被引量:8
  • 4Tanriover B,Carlton D,Saddekni S,et al.Bacteremia associated with tunneled dialysis catheters:comparison of two treatment strategies[J].Kidney Int,2000,57(5):2151-2155.
  • 5Cadman A,Lawrance JA,Fitzsimmons L,et al.To clot or not to Clot?That is the question in central venous catheters[J].Clin Radiol,2004,59(4):349-355.
  • 6Mokrzycki MH,Jean-Jerome K,Rush H,et al.A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled,cuffed hemodialysis catheters[J].Kidney Int,2001,59(5):1935.
  • 7Webb A,Abdalla M,Russell GI.A protocol of urokinase infusion and warfarin for the management of the thrombosed hemodialysis catheter[J].Nephrol Dial Transplant,2001,16(10):2075-2078.
  • 8Zellweger M,Bouchard J,Raymond-Carrier S,et al.Systemic anticoagulation and prevention of hemodialysis catheter malfunction[J].ASAIO J,2005,51(4):360-365.
  • 9Zacharias JM,Weatherston CP,Spewak CR,et al.Alteplase versus urokinase for occluded hemodialysis catheters[J].Ann Pharmacother,2003,37(1):27-33.
  • 10Quarello F, FornerisG,BorcaM,et al. Do central venous cath- eters have advantages over arterioveou fistulas or grafts [J].J Nephrol,2006,19(3):265-279.

共引文献35

同被引文献57

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部